For research use only. Not for therapeutic Use.
LFHP-1c（Cat No.:I041198）is an investigational compound under development for its potential use in treating inflammatory diseases and conditions related to immune system dysregulation. It is designed to selectively target specific pathways involved in inflammation, aiming to modulate immune responses without broadly suppressing immune function. By regulating inflammatory cytokines and immune cell activity, LFHP-1c has shown promise in preclinical studies for conditions like rheumatoid arthritis, inflammatory bowel disease, and other autoimmune disorders. Clinical trials are underway to assess its safety, efficacy, and potential as a therapeutic agent for these chronic inflammatory conditions.
| CAS Number | 2102347-47-5 |
| Synonyms | 1-[2-[8-[[2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoyl]amino]octylcarbamoyl]phenyl]pentyl acetate |
| Molecular Formula | C55H64N6O4 |
| Purity | ≥95% |
| IUPAC Name | 1-[2-[8-[[2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoyl]amino]octylcarbamoyl]phenyl]pentyl acetate |
| InChI | InChI=1S/C55H64N6O4/c1-6-8-28-50(65-39(4)62)44-23-14-16-25-46(44)55(64)57-34-20-12-10-9-11-19-33-56-54(63)45-24-15-13-22-43(45)41-31-29-40(30-32-41)37-61-49-36-42(35-38(3)52(49)59-51(61)21-7-2)53-58-47-26-17-18-27-48(47)60(53)5/h13-18,22-27,29-32,35-36,50H,6-12,19-21,28,33-34,37H2,1-5H3,(H,56,63)(H,57,64) |
| InChIKey | OITTXMIOSJEXLY-UHFFFAOYSA-N |
| SMILES | CCCCC(C1=CC=CC=C1C(=O)NCCCCCCCCNC(=O)C2=CC=CC=C2C3=CC=C(C=C3)CN4C5=C(C(=CC(=C5)C6=NC7=CC=CC=C7N6C)C)N=C4CCC)OC(=O)C |
